What is CEMTREX INC.'s earnings per share (EPS)?

CEMTREX INC. (CETX) reported diluted earnings per share of -$210.88 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CEMTREX INC. (CETX) Financials

CETX

Trailing 12 months to June 30, 2026

Revenue $71.2M -6.5% YoY

Net Income -$27.5M -35.3% YoY

EPS (Diluted) -$210.88 FY2025 annual

Free Cash Flow -$9.6M -1155.3% YoY

Market Cap $3.0M as of Oct 20, 2026

Price / Sales 0.0x on $71.2M revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 0.1x on $32.0M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Aug 14, 2026 Currency USD FYE September

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CETX SEC filings page.

CEMTREX INC. (CETX) reported $71.2M in revenue over the twelve months to Jun 30, 2026, down 6.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CETX FY2025 2026-10-04

Cemtrex reached operating break-even in FY2025, yet a large bottom-line gap left earnings quality unresolved.

The FY2025 operating turnaround did not reach the bottom line: operating income was $510K, while net loss was $28.1M. In FY2024, a $5.3M operating loss accompanied a $7.2M net loss, so the latest divergence points to below-operating-line items—not weak gross margin alone—as the main earnings disconnect.

Gross margin improved to 42.2% in FY2025, but SG&A reached $28.2M; much of the added gross profit was absorbed by overhead. Operating cash flow was only $159K while free cash flow was negative $1.8M, showing that near break-even operations still did not fund capital spending.

Debt-to-equity fell from 2.8x to 0.5x by FY2025, indicating a less debt-heavy capital structure. Yet the current ratio was 1.2x while receivables reached $13.1M; working capital remains tied to customer collections rather than excess liquidity.

Financial Health Signals

Financial Health Score 47/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of CEMTREX INC.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

CEMTREX INC. held $5.0M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $159K of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and CEMTREX INC. scores 85/100 among other emerging companies.

Dilution

CEMTREX INC. had 7M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and CEMTREX INC. scores 8/100 among other emerging companies.

R&D Intensity

CEMTREX INC. spent $2.4M on research and development in fiscal year 2025, which was 3.1% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and CEMTREX INC. scores 18/100 among other emerging companies.

Revenue Progress

CEMTREX INC. reported revenue of $76.5M in fiscal year 2025, against $66.9M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and CEMTREX INC. scores 60/100 among other emerging companies.

Burn Trend

CEMTREX INC.'s operations generated $159K of cash in fiscal year 2025, against $3.9M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and CEMTREX INC. scores 88/100 among other emerging companies.

Balance Sheet

CEMTREX INC.'s cash, cash equivalents and investments came to $5.0M at the end of fiscal year 2025, against $39.1M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and CEMTREX INC. scores 20/100 among other emerging companies.

Altman Z-Score Distress

-1.10

CEMTREX INC. scores -1.10, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($3.0M) relative to total liabilities ($39.1M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

5/9

CEMTREX INC. passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

N/A

CEMTREX INC. reported a net loss of $28.1M while generating $159K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

0.24x

CEMTREX INC. earns $0.24 in operating income for every $1 of interest expense ($510K vs $2.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$18.4M

YoY+8.7%

QoQ+2.1%

5Y CAGR+12.3%

CEMTREX INC. generated $18.4M in revenue in Q3 2026. This represents an increase of 8.7% from the same quarter a year earlier. Against the prior quarter it is up 2.1%.

EBITDA

-$611K

YoY-85.6%

QoQ+63.1%

CEMTREX INC.'s EBITDA was -$611K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 85.6% from the same quarter a year earlier. Against the prior quarter it is up 63.1%.

Net Income

-$4.5M

YoY+3.3%

QoQ-593.9%

CEMTREX INC. reported -$4.5M in net income in Q3 2026. This represents an increase of 3.3% from the same quarter a year earlier. Against the prior quarter it is down 593.9%.

EPS (Diluted)

-$3.27

CEMTREX INC. earned -$3.27 per diluted share (EPS) in Q3 2026.

Cash & Balance Sheet

Free Cash Flow

-$220K

YoY-112.7%

QoQ+95.2%

CEMTREX INC. recorded an outflow of $220K in free cash flow in Q3 2026, representing a cash shortfall after capex. This represents a decrease of 112.7% from the same quarter a year earlier. Against the prior quarter it is up 95.2%.

Cash & Debt

$8.0M

YoY+13.4%

QoQ+21.4%

5Y CAGR-9.1%

10Y CAGR+12.9%

CEMTREX INC. held $8.0M in cash against $8.6M in long-term debt as of Q3 2026.

Shares Outstanding

5Y CAGR-39.2%

CEMTREX INC. had 2M shares outstanding in Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin

41.7%

YoY-1.7pp

QoQ+3.8pp

5Y change+1.8pp

CEMTREX INC.'s gross margin was 41.7% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.

Operating Margin

-6.5%

YoY-2.7pp

QoQ+5.6pp

5Y change+15.8pp

CEMTREX INC.'s operating margin was -6.5% in Q3 2026, reflecting core business profitability. This is down 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.6 percentage points.

Net Margin

-24.3%

YoY+3.0pp

QoQ-29.3pp

5Y change-34.9pp

CEMTREX INC.'s net profit margin was -24.3% in Q3 2026, showing the share of revenue converted to profit. This is up 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 29.3 percentage points.

Return on Equity

-14.0%

YoY+106.3pp

QoQ-16.6pp

CEMTREX INC.'s ROE was -14.0% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 106.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 16.6 percentage points.

Capital Allocation

R&D Spending

$425K

YoY+10.0%

QoQ-22.2%

5Y CAGR-10.9%

CEMTREX INC. invested $425K in research and development in Q3 2026. This represents an increase of 10.0% from the same quarter a year earlier. Against the prior quarter it is down 22.2%.

Capital Expenditures

$630K

YoY+731.4%

QoQ+311.2%

5Y CAGR+30.1%

CEMTREX INC. invested $630K in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 731.4% from the same quarter a year earlier. Against the prior quarter it is up 311.2%.

Share Buybacks

Not reported for Q3 2026.

CETX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CETX quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$71.2M	$76.5M+14.4%	$66.9M+12.6%	$59.4M+31.9%	$45.0M+4.4%	$43.1M-0.9%	$43.5M+10.8%	$39.3M+73.4%	$22.6M-81.2%	$120.6M+28.7%	$93.7M+64.7%	$56.9M+19.4%	$47.7M+248.5%	$13.7M+12.4%	$12.2M-11.4%	$13.7M
Cost of Revenue	$44.0M	$44.2M+12.2%	$39.4M+16.9%	$33.7M+18.3%	$28.5M+8.8%	$26.2M+1.0%	$25.9M+9.3%	$23.7M+64.3%	$14.4M-64.0%	$40.1M+13.0%	$35.5M+42.9%	$24.8M-22.5%	$32.1M+155.9%	$12.5M+16.2%	$10.8M-7.0%	$11.6M
Gross Profit	$27.2M	$32.3M+17.5%	$27.5M+7.0%	$25.7M+55.1%	$16.6M-2.4%	$17.0M-3.7%	$17.6M+13.2%	$15.6M+89.4%	$8.2M-79.4%	$39.9M+36.6%	$29.2M+79.0%	$16.3M+4.7%	$15.6M+1262.1%	$1.1M-16.8%	$1.4M-35.4%	$2.1M
R&D Expenses	$1.8M	$2.4M-29.9%	$3.4M+2.7%	$3.3M-26.5%	$4.4M+40.1%	$3.2M+73.6%	$1.8M+23.3%	$1.5M-73.3%	$5.6M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$31.1M	$28.2M+2.2%	$27.6M+20.4%	$22.9M+8.1%	$21.2M-6.0%	$22.5M+10.7%	$20.4M-5.4%	$21.5M+41.6%	$15.2M-56.3%	$34.8M+44.1%	$24.1M+74.7%	$13.8M+9.9%	$12.6M+1476.4%	$798K+16.8%	$683K-33.5%	$1.0M
Operating Income	-$7.4M	$510K+109.7%	-$5.3M-248.6%	-$1.5M+89.3%	-$14.1M-61.6%	-$8.7M-91.3%	-$4.6M+38.6%	-$7.4M+40.7%	-$12.6M-345.3%	$5.1M+1.0%	$5.1M+102.5%	$2.5M-17.0%	$3.0M+768.7%	$347K-49.9%	$693K-37.3%	$1.1M
EBITDA	N/A	$1.9M+147.3%	-$3.9M-711.9%	-$485K+96.1%	-$12.4M-67.1%	-$7.4M-173.9%	-$2.7M+39.0%	-$4.4M+56.7%	-$10.2M-223.9%	$8.3M+12.2%	$7.4M+124.8%	$3.3M-6.7%	$3.5M+879.9%	$358K-49.7%	$712K-36.9%	$1.1M
Interest Expense	$13.9M	$2.1M-2.7%	$2.2M-56.3%	$5.0M+28.0%	$3.9M+32.8%	$2.9M-36.6%	$4.6M-3.7%	$4.8M+497.9%	$800K-13.4%	$924K+37.2%	$674K+35.7%	$496K+13.6%	$437K+852.8%	$46K+9.0%	$42K+145.2%	-$93K
Income Tax	$711K	$735K+263.3%	$202K-48.7%	$394K+288.3%	-$209K-155.8%	$375K-81.9%	$2.1M+255.3%	-$1.3M+53.3%	-$2.9M-2374.5%	-$116K-110.6%	$1.1M+118784.6%	$917-98.5%	$61K+387.7%	$13K+403.6%	$2K	$0
Net Income	-$27.5M	-$28.1M-288.9%	-$7.2M-378.3%	-$1.5M+88.4%	-$13.0M-266.8%	$7.8M+174.6%	-$10.5M+53.2%	-$22.4M-142.0%	-$9.2M-310.5%	$4.4M-12.1%	$5.0M+76.0%	$2.8M+6.3%	$2.7M+825.1%	$288K-55.5%	$648K-35.9%	$1.0M
EPS (Basic)	N/A	-$210.88+21.7%	-$269.47+98.3%	-$15760.64-106175.4%	-$14.83-74250.0%	$0.02+102.0%	-$1.00+83.5%	-$6.07-574.4%	-$0.90-381.3%	$0.32-45.8%	$0.59+43.9%	$0.41+5.1%	$0.39+3800.0%	$0.01	N/A	$0.02
EPS (Diluted)	—	-$210.88	-$269.47	-$15760.64	-$14.83	$0.02	-$1.00	-$6.07	-$0.90-390.3%	$0.31	$0.59+47.5%	$0.40	$0.39	$0.01-50.0%	$0.02	$0.02
Diluted Shares (Avg)	N/A	132,396	27,240	414	709,488	19M	10M	2M	1M-86.2%	10M	9M+23.2%	7M	7M	41M	N/A	40M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$18.4M+8.7%	$18.1M-33.7%	$16.1M+17.4%	$18.5M+2.2%	$17.0M+15.5%	$27.3M+58.8%	$13.7M-18.6%	$18.1M+9.3%
Cost of Revenue	$10.7M+12.0%	$11.2M-25.7%	$10.5M+30.8%	$11.5M+8.7%	$9.6M+8.9%	$15.1M+47.6%	$8.0M-17.9%	$10.6M+8.1%
Gross Profit	$7.7M+4.4%	$6.8M-43.7%	$5.6M-1.4%	$7.1M-7.0%	$7.4M+25.4%	$12.2M+75.3%	$5.7M-19.5%	$7.6M+11.1%
R&D Expenses	$425K+10.0%	$547K-29.7%	$501K-43.7%	$299K-56.9%	$387K-55.3%	$778K-18.2%	$890K+4.9%	$693K-25.9%
SG&A Expenses	$7.9M+7.8%	$8.0M+23.2%	$7.6M+12.5%	$7.7M+19.7%	$7.3M-7.0%	$6.5M-3.8%	$6.8M+2.3%	$6.4M-17.3%
Operating Income	-$1.2M-85.7%	-$2.2M-147.0%	-$2.8M-23.0%	-$1.2M-270.1%	-$642K+79.8%	$4.6M+547.3%	-$2.3M-209.0%	-$320K-1608.0%
EBITDA	-$611K-85.6%	-$1.7M-133.6%	-$2.4M-23.1%	-$788K-7689.5%	-$329K+88.5%	$4.9M+777.5%	-$1.9M-425.4%	$10K-41.0%
Interest Expense	$470K+1.9%	$562K+24.1%	$12.1M+2405.3%	$712K+51.0%	$462K-11.5%	$453K-23.6%	$484K-17.1%	$472K-62.2%
Income Tax	-$119K-947.9%	$74K-33.2%	$266K+120.9%	$490K+1469.3%	$14K-79.1%	$111K+10.5%	$121K+70.4%	-$36K
Net Income	-$4.5M+3.3%	$907K-89.5%	-$20.6M+28.5%	-$3.4M-175.8%	-$4.6M+48.4%	$8.6M+686.3%	-$28.8M-2281.3%	$4.4M-31.9%
EPS (Basic)	-$3.27+37.2%	$0.12-99.8%	-$7.91+97.9%	-$199.20-110.1%	-$5.21-760.4%	$72.19+102.4%	-$383.87-15627.2%	$1963.45+112.5%
EPS (Diluted)	-$3.27	$0.11	-$7.91	-$199.20	-$5.21	$19.51	-$383.87	$1963.45+112.5%
Diluted Shares (Avg)	1M	10M	3M	N/A	890,432	440,146	74,210	N/A

CETX Balance Sheet

CETX quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$47.8M+8.3%	$44.1M-9.0%	$48.5M+5.9%	$45.8M-13.6%	$52.9M-13.0%	$60.8M+37.0%	$44.4M-32.0%	$65.3M-7.0%	$70.2M+25.2%	$56.0M+148.5%	$22.5M+13.6%	$19.8M+590.5%	$2.9M+71.2%	$1.7M-30.9%	$2.4M
Current Assets	$29.0M+8.7%	$26.7M-8.9%	$29.3M-7.8%	$31.8M-8.6%	$34.7M-4.0%	$36.2M+91.8%	$18.9M-40.8%	$31.9M-31.3%	$46.4M+25.7%	$36.9M+173.1%	$13.5M+17.1%	$11.5M+360.7%	$2.5M+59.5%	$1.6M-34.1%	$2.4M
Cash & Equivalents	$5.0M+27.6%	$3.9M-26.9%	$5.3M-46.1%	$9.9M-35.9%	$15.4M-20.8%	$19.5M+1001.0%	$1.8M+81.8%	$974K-90.7%	$10.4M+72.7%	$6.0M+306.6%	$1.5M+917.7%	$146K+118.2%	$67K-79.9%	$333K-19.8%	$415K
Short-Term Investments	$0	$0-100.0%	$14K-0.4%	$14K-8.4%	$15K-98.3%	$888K+115.1%	$413K	$0	$0	$0	$0-100.0%	$560K	$0	$0	$0
Inventory	$6.6M-5.8%	$7.0M-20.0%	$8.7M+3.0%	$8.5M+50.0%	$5.7M+14.4%	$4.9M-5.0%	$5.2M-54.1%	$11.4M-34.3%	$17.3M+22.7%	$14.1M+120.9%	$6.4M+1.6%	$6.3M+3835.0%	$159K-19.0%	$197K-38.1%	$318K
Accounts Receivable	$13.1M+17.7%	$11.2M+21.2%	$9.2M+70.6%	$5.4M-30.9%	$7.8M+16.8%	$6.7M+3.5%	$6.5M-53.7%	$13.9M-9.8%	$15.5M+13.9%	$13.6M+184.4%	$4.8M+18.1%	$4.0M+529.7%	$641K+118.7%	$293K+12.1%	$262K
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$80K	$0
Goodwill	$3.7M0.0%	$3.7M-15.4%	$4.4M+12.2%	$3.9M-50.0%	$7.8M+8.3%	$7.2M+65.2%	$4.4M+31.5%	$3.3M0.0%	$3.3M+261.6%	$919K+8.7%	$845K0.0%	$845K	$0	N/A	N/A
Total Liabilities	$39.1M-0.2%	$39.2M-2.4%	$40.1M+28.9%	$31.1M+5.9%	$29.4M-8.1%	$32.0M+42.6%	$22.4M-25.2%	$30.0M-3.8%	$31.2M-22.7%	$40.3M+161.6%	$15.4M-4.8%	$16.2M+829.6%	$1.7M+108.5%	$836K-64.2%	$2.3M
Current Liabilities	$23.8M+28.1%	$18.6M-32.0%	$27.3M+7.2%	$25.5M+29.8%	$19.7M+20.6%	$16.3M+4.2%	$15.6M-28.6%	$21.9M+9.2%	$20.1M-20.2%	$25.2M+185.0%	$8.8M+40.8%	$6.3M+887.1%	$635K+76.8%	$359K-55.9%	$814K
Non-Current Liabilities	$15.2M-25.8%	$20.6M+61.1%	$12.8M+127.7%	$5.6M-42.4%	$9.7M-38.0%	$15.7M+131.1%	$6.8M-16.1%	$8.1M-27.2%	$11.1M-26.3%	$15.1M+129.0%	$6.6M-33.6%	$9.9M+796.6%	$1.1M+132.4%	$476K-68.7%	$1.5M
Long-Term Debt	$4.6M-65.4%	$13.3M+33.6%	$9.9M+319.4%	$2.4M-85.6%	$16.4M-15.5%	$19.4M+96560.8%	$20K-99.8%	$9.9M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$8.7M+85.1%	$4.7M-38.7%	$7.7M-44.9%	$13.9M-38.3%	$22.6M-18.8%	$27.8M+59.1%	$17.5M-50.5%	$35.3M-9.5%	$39.0M+158.4%	$15.1M+111.7%	$7.1M+95.6%	$3.6M+222.1%	$1.1M+34.2%	$843K+791.9%	$94K
Retained Earnings	-$99.4M-39.3%	-$71.4M-11.3%	-$64.1M-16.7%	-$54.9M-31.1%	-$41.9M-22.9%	-$34.1M-44.3%	-$23.6M-654.3%	$4.3M-70.4%	$14.4M+26.2%	$11.4M+77.7%	$6.4M+79.0%	$3.6M+288.9%	$924K+45.4%	$635K+5047.1%	-$13K

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$70.0M+49.1%	$70.7M+53.0%	$60.3M+29.2%	$47.8M+8.3%	$47.0M+7.2%	$46.2M-2.1%	$46.7M+3.1%	$44.1M-9.0%
Current Assets	$37.5M+27.9%	$37.9M+32.6%	$42.7M+47.1%	$29.0M+8.7%	$29.3M+11.0%	$28.6M+0.7%	$29.0M+10.0%	$26.7M-8.9%
Cash & Equivalents	$8.0M+13.4%	$6.6M+44.7%	$20.5M+385.4%	$5.0M+27.6%	$7.0M+8.7%	$4.5M+55.6%	$4.2M+49.0%	$3.9M-26.9%
Short-Term Investments	$3.7M	$5.0M	$0	$0	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%
Inventory	$8.0M+37.9%	$6.7M+9.8%	$7.4M-33.1%	$6.6M-5.8%	$5.8M-22.6%	$6.1M-17.0%	$11.1M+40.0%	$7.0M-20.0%
Accounts Receivable	$12.5M-1.3%	$13.3M+4.8%	$9.7M+5.4%	$13.1M+17.7%	$12.7M+62.5%	$12.7M+10.2%	$9.2M-7.1%	$11.2M+21.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$7.7M+107.3%	$7.7M+107.3%	$3.7M0.0%	$3.7M0.0%	$3.7M-12.5%	$3.7M-15.4%	$3.7M-15.4%	$3.7M-15.4%
Total Liabilities	$38.0M-11.8%	$36.0M-8.8%	$31.2M-35.2%	$39.1M-0.2%	$43.1M-0.8%	$39.5M-6.1%	$48.2M+26.8%	$39.2M-2.4%
Current Liabilities	$24.3M-0.2%	$24.2M+2.8%	$18.0M-27.9%	$23.8M+28.1%	$24.4M+74.2%	$23.6M+30.2%	$24.9M-13.2%	$18.6M-32.0%
Non-Current Liabilities	$13.7M-27.0%	$11.8M-25.9%	$13.3M-42.9%	$15.2M-25.8%	$18.7M-36.5%	$15.9M-33.6%	$23.3M+150.5%	$20.6M+61.1%
Long-Term Debt	$8.6M+1.2%	$8.8M-7.8%	$8.0M-32.4%	$4.6M-65.4%	$8.5M-49.8%	$9.5M-56.0%	$11.9M	$13.3M+33.6%
Total Equity	$32.0M+730.7%	$34.7M+415.9%	$29.1M+1965.3%	$8.7M+85.1%	$3.9M+7932.4%	$6.7M+43.5%	-$1.6M-123.1%	$4.7M-38.7%
Retained Earnings	-$123.5M-28.3%	-$119.0M-29.8%	-$120.0M-19.8%	-$99.4M-39.3%	-$96.3M-27.0%	-$91.7M-37.3%	-$100.1M-53.2%	-$71.4M-11.3%

CETX Cash Flow Statement

CETX quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$8.2M	$159K+104.0%	-$3.9M-76.9%	-$2.2M+86.1%	-$16.1M-60.1%	-$10.1M-165.5%	-$3.8M-196.2%	$3.9M+258.6%	-$2.5M-349.3%	$995K-87.4%	$7.9M+103.5%	$3.9M+265.6%	-$2.3M-276.0%	-$623K-166.2%	$941K+1027.3%	-$102K
Depreciation & Amortization	N/A	$1.4M+2.0%	$1.3M+29.5%	$1.0M-41.4%	$1.8M+31.2%	$1.3M-28.4%	$1.9M-38.1%	$3.0M+29.9%	$2.3M-26.2%	$3.1M+36.8%	$2.3M+197.2%	$772K+56.2%	$495K+4339.1%	$11K-40.9%	$19K-17.8%	$23K
Stock-Based Compensation	N/A	$14K-52.9%	$30K-71.7%	$107K-31.3%	$156K-0.6%	$156K-18.3%	$191K-69.2%	$622K+52.5%	$408K+504.4%	$68K+30.1%	$52K-9.4%	$57K	$0	N/A	$0	$0
Capital Expenditures	$1.5M	$1.9M+48.9%	$1.3M-53.0%	$2.8M+55.7%	$1.8M+65.9%	$1.1M	N/A	$1.7M-86.4%	$12.2M+115.0%	$5.7M+755.3%	$664K-56.2%	$1.5M-43.8%	$2.7M	N/A	N/A	N/A
Free Cash Flow	-$9.6M	-$1.8M+66.2%	-$5.2M-5.1%	-$5.0M+72.0%	-$17.9M-60.7%	-$11.1M	N/A	$2.3M+115.5%	-$14.7M-213.7%	-$4.7M-164.7%	$7.2M+205.9%	$2.4M+146.9%	-$5.0M	N/A	N/A	N/A
Investing Cash Flow	-$14.8M	-$3.0M-135.5%	-$1.3M+77.7%	-$5.6M-185.1%	$6.6M+686.1%	$841K+134.6%	-$2.4M-135.6%	$6.8M+156.0%	-$12.2M-115.0%	-$5.7M+66.9%	-$17.1M-1693.5%	-$956K	N/A	N/A	-$82K	$0
Financing Cash Flow	$24.1M	$4.1M-7.4%	$4.4M+116.0%	$2.0M-59.4%	$5.0M+13.0%	$4.4M-81.8%	$24.4M+305.9%	-$11.9M-321.6%	$5.4M-46.0%	$9.9M-28.2%	$13.8M+972.3%	-$1.6M	N/A	$357K+134.9%	-$1.0M-315.2%	$476K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$529K	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$410K-77.3%	-$4.4M-257.7%	-$892K+25.8%	-$3.3M-73.6%	$1.8M+167.9%	$2.8M+624.4%	-$1.2M+61.7%	-$1.9M-372.8%
Depreciation & Amortization	$582K+85.9%	$516K+66.2%	$412K+22.3%	$395K+19.5%	$313K-3.9%	$310K+1.8%	$337K-8.4%	$330K+0.7%
Stock-Based Compensation	N/A	N/A	$0-100.0%	N/A	$3K-59.0%	$3K-59.0%	$4K-45.9%	N/A
Capital Expenditures	$630K+731.4%	$153K-64.8%	$184K-80.1%	$496K-42.9%	$76K+2.4%	$436K+573.8%	$924K+218.0%	$868K-56.6%
Free Cash Flow	-$220K-112.7%	-$4.6M-293.2%	-$1.1M+49.4%	-$3.7M-36.7%	$1.7M+188.2%	$2.4M+634.6%	-$2.1M+38.0%	-$2.7M-108.7%
Investing Cash Flow	$694K+1615.7%	-$13.7M-3108.8%	-$253K+74.9%	-$1.5M-73.7%	-$46K-193.3%	-$428K-557.8%	-$1.0M-158.5%	-$851K+82.6%
Financing Cash Flow	$280K+227.4%	$3.6M+363.2%	$17.3M+624.8%	$3.0M+456.9%	$86K-96.7%	-$1.4M-636.8%	$2.4M+139.2%	$531K-84.0%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

CETX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CETX quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	42.2%+1.1pp	41.1%-2.2pp	43.3%+6.5pp	36.8%-2.6pp	39.3%-1.1pp	40.5%+0.9pp	39.6%+3.3pp	36.3%+3.2pp	33.1%+1.9pp	31.2%+2.5pp	28.7%-4.0pp	32.7%+24.4pp	8.4%-2.9pp	11.3%-4.2pp	15.5%
Operating Margin	0.7%+8.5pp	-7.9%-5.3pp	-2.5%+28.8pp	-31.4%-11.1pp	-20.3%-9.8pp	-10.5%+8.5pp	-19.0%+36.5pp	-55.4%-59.7pp	4.2%-1.2pp	5.4%+1.0pp	4.4%-1.9pp	6.3%+3.8pp	2.5%-3.2pp	5.7%-2.3pp	8.0%
Net Margin	-36.8%-25.9pp	-10.8%-8.3pp	-2.5%+26.4pp	-28.9%-47.0pp	18.1%+42.2pp	-24.1%+32.9pp	-57.0%-16.1pp	-40.8%-44.5pp	3.6%-1.7pp	5.3%+0.3pp	5.0%-0.6pp	5.6%+3.5pp	2.1%-3.2pp	5.3%-2.0pp	7.4%
Return on Equity	-322.5%-169.0pp	-153.5%-133.8pp	-19.7%+73.7pp	-93.4%-127.9pp	34.6%+72.2pp	-37.6%+90.3pp	-128.0%-101.8pp	-26.2%-37.5pp	11.3%-21.8pp	33.1%-6.7pp	39.8%-33.4pp	73.3%+47.8pp	25.5%-51.4pp	76.9%-993.0pp	1069.9%
Return on Assets	-58.8%-42.4pp	-16.4%-13.3pp	-3.1%+25.3pp	-28.5%-43.2pp	14.8%+32.0pp	-17.2%+33.2pp	-50.4%-36.2pp	-14.2%-20.4pp	6.3%-2.6pp	8.9%-3.7pp	12.6%-0.9pp	13.5%+3.4pp	10.0%-28.6pp	38.6%-3.0pp	41.6%
Current Ratio	1.22-0.2x	1.44+0.4x	1.07-0.2x	1.25-0.5x	1.77-0.5x	2.22+1.0x	1.21-0.2x	1.46-0.9x	2.31+0.8x	1.47-0.1x	1.53-0.3x	1.84-2.1x	3.95-0.4x	4.38+1.4x	2.93
Debt-to-Equity	0.53-2.3x	2.82+1.5x	1.29+1.1x	0.17-0.6x	0.730.0x	0.70+0.7x	0.00-0.3x	0.28-0.5x	0.80-1.9x	2.67+0.5x	2.16-2.3x	4.45+2.9x	1.54+0.5x	0.99-23.7x	24.71
Asset Turnover	1.60+0.1x	1.52+0.3x	1.23+0.2x	0.98+0.2x	0.81+0.1x	0.72-0.2x	0.88+0.5x	0.35-1.4x	1.720.0x	1.67-0.9x	2.52+0.1x	2.40-2.4x	4.76-2.5x	7.25+1.6x	5.65
FCF Margin	-2.3%+5.5pp	-7.8%+0.6pp	-8.4%+31.3pp	-39.7%-13.9pp	-25.8%	N/A	5.8%+70.7pp	-64.9%-61.0pp	-3.9%-11.6pp	7.7%+3.6pp	4.2%+14.7pp	-10.6%	N/A	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	41.7%-1.7pp	37.9%-6.7pp	34.8%-6.7pp	38.0%-3.7pp	43.4%+3.4pp	44.6%+4.2pp	41.5%-0.5pp	41.8%+0.7pp
Operating Margin	-6.5%-2.7pp	-12.0%-29.0pp	-17.4%-0.8pp	-6.4%-4.6pp	-3.8%+17.9pp	16.9%+22.9pp	-16.6%-12.2pp	-1.8%-1.7pp
Net Margin	-24.3%+3.0pp	5.0%-26.7pp	-127.4%	-18.1%-42.6pp	-27.3%+33.8pp	31.7%+40.3pp	-209.3%	24.4%-14.8pp
Return on Equity	-14.0%+106.3pp	2.6%-125.8pp	-70.7%	-38.6%-132.7pp	-120.3%+18607.3pp	128.4%+159.8pp	N/A	94.1%+9.4pp
Return on Assets	-6.4%+3.5pp	1.3%-17.4pp	-34.1%+27.5pp	-7.0%-17.1pp	-9.9%+10.6pp	18.7%+21.8pp	-61.6%-58.9pp	10.1%-3.4pp
Current Ratio	1.54+0.3x	1.57+0.4x	2.38+1.2x	1.22-0.2x	1.20-0.7x	1.21-0.4x	1.17+0.2x	1.44+0.4x
Debt-to-Equity	0.27-1.9x	0.25-1.2x	0.28	0.53-2.3x	2.20-350.1x	1.41-3.2x	N/A	2.82+1.5x
Asset Turnover	0.26-0.1x	0.26-0.3x	0.270.0x	0.390.0x	0.360.0x	0.59+0.2x	0.29-0.1x	0.41+0.1x
FCF Margin	-1.2%-11.4pp	-25.3%-34.0pp	-6.7%+8.8pp	-20.2%-5.1pp	10.2%+6.1pp	8.7%+6.8pp	-15.5%+4.8pp	-15.1%-7.2pp

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
CEMTREX INC. CETX	FY2025	$76.5M	-$28.1M	-36.8%	$3.0M	47/100
Taoping Inc. BVI TAOP	FY2025	$30.8M	-$10.1M	-32.6%	$3.2M	25/100
AtlasClear Holdings, Inc. ATCH	FY2026	$20.1M	$2.0M	9.8%	$24.8M	51/100
Ryvyl Inc. RVYL	FY2025	$11.1M	-$17.5M	N/A	$10.0M	28/100
Brand Engagement Network Inc. BNAI	FY2025	$275K	-$8.6M	N/A	$42.5M	—
The OLB Group, Inc. OLB	FY2025	$8.7M	-$6.7M	-77.0%	$11.0M	19/100

Where CEMTREX INC. Ranks

Frequently Asked Questions

What is CEMTREX INC.'s annual revenue?

CEMTREX INC. (CETX) reported $76.5M in total revenue for fiscal year 2025. This represents a 14.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CEMTREX INC.'s revenue growing?

CEMTREX INC. (CETX) revenue grew by 14.4% year-over-year, from $66.9M to $76.5M in fiscal year 2025.

Is CEMTREX INC. profitable?

No, CEMTREX INC. (CETX) reported a net income of -$28.1M in fiscal year 2025, with a net profit margin of -36.8%.

What is CEMTREX INC.'s EBITDA?

CEMTREX INC. (CETX) had EBITDA of $1.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does CEMTREX INC. have?

As of fiscal year 2025, CEMTREX INC. (CETX) had $5.0M in cash and equivalents against $4.6M in long-term debt.

What is CEMTREX INC.'s gross margin?

CEMTREX INC. (CETX) had a gross margin of 42.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is CEMTREX INC.'s operating margin?

CEMTREX INC. (CETX) had an operating margin of 0.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is CEMTREX INC.'s net profit margin?

CEMTREX INC. (CETX) had a net profit margin of -36.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is CEMTREX INC.'s return on equity (ROE)?

CEMTREX INC. (CETX) has a return on equity of -322.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is CEMTREX INC.'s free cash flow?

CEMTREX INC. (CETX) recorded an outflow of $1.8M in free cash flow during fiscal year 2025. This represents a 66.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is CEMTREX INC.'s operating cash flow?

CEMTREX INC. (CETX) generated $159K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are CEMTREX INC.'s total assets?

CEMTREX INC. (CETX) had $47.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are CEMTREX INC.'s capital expenditures?

CEMTREX INC. (CETX) invested $1.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does CEMTREX INC. spend on research and development?

CEMTREX INC. (CETX) invested $2.4M in research and development during fiscal year 2025.

How many shares does CEMTREX INC. have outstanding?

CEMTREX INC. (CETX) had 7M shares outstanding as of fiscal year 2025.

What is CEMTREX INC.'s current ratio?

CEMTREX INC. (CETX) had a current ratio of 1.22 as of fiscal year 2025, which is considered adequate.

What is CEMTREX INC.'s debt-to-equity ratio?

CEMTREX INC. (CETX) had a debt-to-equity ratio of 0.53 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is CEMTREX INC.'s return on assets (ROA)?

CEMTREX INC. (CETX) had a return on assets of -58.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is CEMTREX INC.'s P/E ratio?

CEMTREX INC. (CETX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $3.0M as of Oct 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is CEMTREX INC.'s price-to-sales ratio?

CEMTREX INC. (CETX) trades at 0.0x sales, its market capitalization divided by revenue of $71.2M revenue, trailing 12 months to June 30, 2026. The market capitalization is $3.0M as of Oct 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is CEMTREX INC.'s Altman Z-Score?

CEMTREX INC. (CETX) has an Altman Z-Score of -1.10, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is CEMTREX INC.'s Piotroski F-Score?

CEMTREX INC. (CETX) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CEMTREX INC.'s earnings high quality?

CEMTREX INC. (CETX) reported a net loss of $28.1M while generating $159K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can CEMTREX INC. cover its interest payments?

CEMTREX INC. (CETX) has an interest coverage ratio of 0.24x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is CEMTREX INC.?

CEMTREX INC. (CETX) scores 47 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.